Earnings per share for the last twelve months: MangoRx (MGRX)

MGRX (MangoRx) - company brandmark

The TTM net income per share reflects the profitability dynamics of Mangoceuticals, Inc. (MGRX), where -1.17 characterizes this valuation parameter. The financial result is based on user acquisition costs and compliance with online pharmacy regulations. The scaling of MangoRx and the development of the subscription service are driving growth. Ambitious management is ensuring a rapid surge in revenue, although the market is awaiting the optimization of current expenses.

MGRX (Mangoceuticals, Inc.) Net earnings per share for the trailing year history from 04/28/2023 to 11/14/2026

MGRX (Mangoceuticals Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price MangoRx|MGRX - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Mangoceuticals, Inc.|MGRX - Business Value
- shareholders' equity book value data:
Book Value per Share Mangoceuticals|MGRX - Book Value of Business|Market Value to Book Value Ratio mangorx.com|MGRX - Company Assets
- debt burden and liquidity indicators:
Total Debt to Capital Mangoceuticals, Inc.|MGRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital MangoRx|MGRX - Company Cumulative Debt|Debt to Book Value Mangoceuticals, Inc.|MGRX - Company Long-Term Debts|Company Current Liabilities Mangoceuticals|Quick Ratio mangorx.com
- net income and valuation multiples indicators:
MGRX - Net Financial Result|Projected Future Earnings Mangoceuticals, Inc.|MGRX - Price to Earnings Ratio|Forward P/E Multiple MangoRx|MGRX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Mangoceuticals, Inc.|MGRX - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Mangoceuticals|MGRX - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months mangorx.com|MGRX - Earnings per share increase in current year|Earnings growth forecast for next year Mangoceuticals, Inc.
- sales volume and revenue indicators:
MGRX - Company Gross Revenue|Company Projected Revenue MangoRx|MGRX - Market Cap to Revenue Ratio|Forward P/S Multiple Mangoceuticals, Inc.
Basic company analysis:mangorx.com - MGRX
Manufactured products of Mangoceuticals Inc.

Mangoceuticals, Inc. (MGRX) revenues depend directly on customer acquisition costs within the men's telemedicine segment and regulatory standards. This indicator measures the actual annual earnings per share, excluding management's accounting manipulations. Rising values signal marketing efficiency and business scaling. Analyzing the fundamental net income per share TTM allows for timely portfolio rebalancing. The trend in fundamental net income per share TTM reflects the market consensus on the cost of capital.

Competitors of Mangoceuticals, Inc. (MGRX)

Hims & Hers Health - Net earnings per share (EPS TTM)|HNGE - Net earnings per share (EPS TTM)|Teladoc (TDOC) - Earnings per share for the last twelve months|Earnings per share for the last 12 months TALK|LFMD (LifeMD Inc.) - Net earnings per share (EPS TTM)|AMWL - Net earnings per share for the trailing year|Earnings per share for the last twelve months DarioHealth Corp. (DRIO)|VSEE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) MNDR (Mobile-health Network Solutions)|ACCD - Net earnings per share for the last 12 months|Biotricity, Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lytus|OTRK (Ontrak, Inc.) - Net earnings per share for the last 12 months|SHL Telemedicine (SHLT) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months THRN